![](http://www.uhnresearch.ca/sites/default/files/news_images/kevinspicOct1.jpg)
By: Kevin Robb, Office of Research Trainee (ORT) Science Writer
In 1997, Health Canada released guidelines stating that clinical trials for drug development should include women. In the decades prior, many drugs had not been tested on women before they were prescribed to them—an omission that bore dire consequences for women’s health. Sex and gender represent major variables in health research; however, many scientists remain uncertain on how to incorporate these factors in their research. Below are some tips for researchers to begin tackling this question based on content from the Canadian Institutes of Health Research (CIHR).
Use the right language: Researchers frequently use the terms “sex” and “gender” interchangeably, but these terms have distinct definitions that need to be carefully considered at every use. Sex refers to a set of biological characteristics including reproductive anatomy, hormone levels and genetics; it includes the female and male sexes, as well as intersex. In contrast, gender is a sociocultural phenomenon relating to an individual’s identity and how they fundamentally perceive themselves. Gender is not confined to girl/woman and boy/man; rather, it exists on a continuum that includes non-binary and other gender diversities. Importantly, gender is culturally specific and it can change over time.
Incorporating sex and gender in study designs: All good science starts with a literature review and sex and gender considerations are no exception. Researchers should investigate what is known about the influence of sex and gender in their area of study (while keeping an eye out for incorrect uses of the terms). This should inform the integration of sex and gender variables in the subsequent study design as this is now a requirement of most funding agencies. Sex should be specified in animal studies and work involving human cells or tissues because it is a biological variable. Notably, male rodents—often thought to provide more consistent data due to absence of the estrous cycle—are no more variable than females for many applications.
For studies involving human participants, researchers should consider sex and gender in study designs. Data collection should be sensitive to sex and gender issues, and researchers may consider a two-step method to separately obtain sex and gender information. Regardless of the study type, researchers should be prepared to justify their decision if only one sex or gender is included.
Reporting on sex and gender factors: The sex of animals and human-derived cells or tissues should be reported in all studies. Similarly, patient demographics on sex and gender should be included for human studies when available. CIHR recommends that researchers incorporate sex- and gender-based analyses and accurately report the results of these analyses. In terms of knowledge translation, researchers should take gender into account to ensure their findings resonate with their intended audience while considering the social context of their work and avoiding reinforcement of gender stereotypes.
Substantially more research is needed to better understand influences of sex and gender on human health and disease. The same rigour that is applied to other aspects of a research study should also extend to sex and gender considerations.